InsiderClue
Insiders · Profile

BARTHELEMY NICOLAS

Director at REPLIGEN · Director at Twist Bioscience · VP, Corporate Development at 908 Devices · and 1 more. Filing since 9 May 2018. CIK 0001283576

RGEN REPLIGEN CORP Director · 8 trades TWST Twist Bioscience Corp Director · 2 trades MASS 908 Devices Inc. VP, Corporate Development · 4 trades LAB STANDARD BIOTOOLS INC. Director · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RGEN REPLIGEN CORP
14 Jun 2024
Director
Bought
1,200
$150.54K
34.6%
TWST Twist Bioscience Corp
11 May 2022
Director
Bought
8,550
$250.10K
159%
RGEN REPLIGEN CORP
29 Oct 2021
Director
Sold, plan not stated
1,645
$474.09K
51.5%
MASS 908 Devices Inc.
24 Jun 2021
VP, Corporate Development
Sold, plan not stated
4,000
$160.00K
100%
MASS 908 Devices Inc.
23 Jun 2021
VP, Corporate Development
Sold, plan not stated
6,000
$237.78K
30.7%
MASS 908 Devices Inc.
23 Jun 2021
VP, Corporate Development
Sold, plan not stated
3,000
$118.59K
100%
TWST Twist Bioscience Corp
9 Feb 2021
Director
Sold, plan not stated
5,000
$888.03K
72.5%
MASS 908 Devices Inc.
22 Dec 2020
Director
Bought
14,000
$280.00K
opened
RGEN REPLIGEN CORP
9 Nov 2020
Director
Sold, plan not stated
1,214
$237.35K
45.6%
RGEN REPLIGEN CORP
18 May 2020
Director
Sold, plan not stated
3,009
$428.87K
53.0%
RGEN REPLIGEN CORP
22 Apr 2020
Director
Sold, plan not stated
2,688
$295.65K
47.0%
RGEN REPLIGEN CORP
3 Apr 2020
Director
Sold, plan not stated
2,688
$268.77K
39.8%
LAB STANDARD BIOTOOLS INC.
6 Mar 2020
Director
Bought
80,000
$243.87K
115%
LAB STANDARD BIOTOOLS INC.
13 Feb 2020
Director
Bought
12,257
$44.61K
21.5%
LAB STANDARD BIOTOOLS INC.
17 Jun 2019
Director
Sold, plan not stated
5,100
$63.40K
10.9%
RGEN REPLIGEN CORP
29 Aug 2018
Director
Sold, plan not stated
6,580
$358.20K
61.1%
RGEN REPLIGEN CORP
9 May 2018
Director
Sold, plan not stated
26,500
$1.07M
84.5%
17 decisions on file.